Ligand binding to I2 imidazoline receptor: The role of lipophilicity in quantitative structure—activity relationship models
- 1 December 1998
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry
- Vol. 6 (12), 2245-2260
- https://doi.org/10.1016/s0968-0896(98)80005-9
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Potential Mechanisms of Moxonidine-Induced Ocular Hypotension: Role of NorepinephrineJournal of Ocular Pharmacology and Therapeutics, 1997
- Stimulation of insulin release from the MIN6 cell line by a new imidazoline compound, S‐21663: evidence for the existence of a novel imidazoline site in β cellsBritish Journal of Pharmacology, 1997
- Central imidazoline (I1) receptors as targets of centrally acting antihypertensivesJournal Of Hypertension, 1997
- Imidazoline receptorsNeurochemistry International, 1997
- Centrally acting antihypertensivesJournal Of Hypertension, 1997
- IMIDAZOLINE BINDING SITES AND SIGNAL TRANSDUCTION PATHWAYSClinical and Experimental Pharmacology and Physiology, 1996
- Functional Studies of Specific Imidazoline‐2 Receptor LigandsAnnals of the New York Academy of Sciences, 1995
- The effects of chronic imidazoline drug treatment on glial fibrillary acidic protein concentrations in rat brainBritish Journal of Pharmacology, 1994
- Keeping an eye on the I site: imidazoline-prefemng receptorsTrends in Pharmacological Sciences, 1992
- Effects of imidazole compounds on catecholamine release in adrenal chromaffin cellsCellular and Molecular Neurobiology, 1992